Good news: its temporary
It acts on GLP-1, GIP and glucagon receptors and has attracted strong interest in metabolic research, particularly in models of appetite regulation, body-weight change, glycaemic control and energy balance
Recommended monitoring protocol: Baseline: Full thyroid panel (TSH, free T4, free T3, TPO antibodies, thyroglobulin antibodies) plus thyroid ultrasound before starting GLP-1 therapy 6-8 weeks after starting GLP-1: Recheck TSH and free T4
The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research
Subcutaneous bioavailability is nearly complete thanks to albumin binding conferred by the C20 chain
Youll be working with Bonnie Lea Davis, FNP-C , a Board-Certified Nurse Practitioner specializing in GLP-1 and GIP weight loss treatments